Saturated fat and Type 2 diabetes: where do we stand?
Dietary treatment of Type 2 diabetes has long been open to controversy and debate, and this is especially true of the relationship between saturated fat (SFA) and cardiovascular disease (CVD). Over the past couple of years, various studies [1–3] have resulted in headlines claiming that experts have...
Autor principal: | Dyson, P |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Wiley
2016
|
Ítems similars
-
Foot practices in patients with type 2 diabetes: Where do we stand?
per: Tehseen Fatima, et al.
Publicat: (2020-01-01) -
Where do we stand on human diabetic nephropathy?
per: Dae Ryong Cha
Publicat: (2013-09-01) -
Diabetes Care in Iran: Where We Stand and Where We Are Headed
per: Sina Noshad, et al.
Publicat: (2016-04-01) -
Diabetic kidney disease, revisited: where do we stand?
per: Dae Ryong Cha
Publicat: (2022-09-01) -
Screening and Diagnosis of Gestational Diabetes Mellitus, Where Do We Stand
per: P. Reddi Rani, et al.
Publicat: (2016-04-01)